Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
Select Page
TruLite Health Partners with Lee Health to Elevate Health Equity Strategy

TruLite Health Partners with Lee Health to Elevate Health Equity Strategy

by Xcellerant Ventures | Nov 2, 2024 | Portfolio Company News

Origionally posted on Business Wire: https://www.businesswire.com/news/home/20241101478105/en/TruLite-Health-Partners-with-Lee-Health-to-Elevate-Health-Equity-Strategy   TEMPE, Ariz.–(BUSINESS WIRE)–TruLite Health, developer of the only health equity...
TruLite Health Selected for Microsoft Pegasus Program

TruLite Health Selected for Microsoft Pegasus Program

by Xcellerant Ventures | Oct 3, 2024 | Portfolio Company News

Origionally posted on TruLite Health website: https://trulitehealth.com/trulite-health-selected-for-microsoft-for-startups-pegasus-program/ TEMPE, ARIZ. (October 03, 2024) – TruLite Health, developer of the only health equity solution to remediate clinical bias, is...
Xcellerant Ventures Leads DeepLook Medical’s Series A Round

Xcellerant Ventures Leads DeepLook Medical’s Series A Round

by Xcellerant Ventures | Sep 24, 2024 | Portfolio Company News, Xcellerant Ventures News

Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240924360690/en/Xcellerant-Ventures-Leads-DeepLook-Medical%E2%80%99s-Series-A-Round   SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures is proud to announce that it will lead...
DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates

DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates

by Xcellerant Ventures | Sep 17, 2024 | Portfolio Company News

Origionally posted on DeepLook Medical’s Website: https://www.deeplookmedical.com/post/deeplook-medical-s-dl-precise-improved-the-performance-of-the-breast-imaging-department-with-12-fa   Finding cancer in a mammogram is difficult, especially with women who...
Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

by Xcellerant Ventures | Aug 21, 2024 | Portfolio Company News

Origionally posted on Health Innovation Oxford’s website: https://www.healthinnovationoxford.org/our-work/strategic-and-industry-partnerships-2/economic-growth-case-studies/digital-health-oncology-platform-supports-better-outcomes-for-prostate-cancer-patients/...
CRISPR QC Launches Three Innovative Products and Unveils Revamped Website

CRISPR QC Launches Three Innovative Products and Unveils Revamped Website

by Xcellerant Ventures | Aug 12, 2024 | Portfolio Company News

Origionally posted on EIN Presswire: https://www.einpresswire.com/article/710284206/lenoss-medical-oversubscribes-4-million-series-a-financing   SAN DIEGO–(BUSINESS WIRE)–CRISPR QC, a pioneering biotechnology company in San Diego, is excited to...
« Older Entries

Recent Posts

  • TruLite Health Partners with Lee Health to Elevate Health Equity Strategy
  • TruLite Health Selected for Microsoft Pegasus Program
  • Xcellerant Ventures Leads DeepLook Medical’s Series A Round
  • DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
  • Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023